| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.801 | 150.982 | 322.988 | 1.198.432 | 1.506.619 | 1.457.130 | 1.674.597 | 1.966.013 |
| Total Income - EUR | - | - | 2.810 | 165.074 | 330.385 | 1.204.451 | 1.515.067 | 1.461.536 | 1.676.224 | 1.967.385 |
| Total Expenses - EUR | - | - | 9.149 | 94.912 | 251.884 | 848.220 | 1.116.579 | 1.183.877 | 1.427.722 | 1.625.372 |
| Gross Profit/Loss - EUR | - | - | -6.339 | 70.162 | 78.502 | 356.231 | 398.488 | 277.659 | 248.502 | 342.013 |
| Net Profit/Loss - EUR | - | - | -6.367 | 68.647 | 75.250 | 333.587 | 350.301 | 245.816 | 220.072 | 303.069 |
| Employees | - | - | 1 | 3 | 8 | 29 | 38 | 37 | 38 | 39 |
Check the financial reports for the company - Pharmacons Phvc Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.966 | 23.074 | 25.085 | 33.205 | 26.871 | 43.673 | 38.221 | 29.032 |
| Current Assets | - | - | 5.200 | 76.687 | 108.455 | 422.759 | 432.635 | 528.234 | 480.986 | 571.251 |
| Inventories | - | - | 0 | 0 | 0 | 34 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 3.002 | 11.114 | 36.160 | 27.834 | 163.690 | 436.446 | 319.661 | 546.809 |
| Cash | - | - | 2.198 | 65.573 | 72.294 | 394.891 | 268.945 | 91.788 | 161.325 | 24.442 |
| Shareholders Funds | - | - | -6.324 | 62.439 | 75.368 | 335.168 | 354.595 | 256.788 | 243.594 | 334.216 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 15.240 | 18.597 | 46.358 | 112.733 | 102.033 | 318.169 | 279.226 | 273.972 |
| Income in Advance | - | - | 0 | 20.005 | 13.778 | 9.216 | 4.945 | 2.934 | 2.280 | 1.705 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Pharmacons Phvc Srl